Early recanalization rate of major occluded brain arteries after intravenous tissue plasminogen activator therapy using serial magnetic resonance angiography studies

European Neurology

Volumn 62, Issue 5, 2009, Pages 287-292

  Kimura, Kazumi ^a   Iguchi, Yasuyuki ^a   Shibazaki, Kensaku ^a   Aoki, Junya ^a   Uemura, Junichi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Acute stroke; Magnetic resonance angiography; Recanalization thrombolysis; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; PRIORITY JOURNAL; RECANALIZATION; TREATMENT OUTCOME; BRAIN ARTERY; BRAIN ISCHEMIA; DRUG EFFECT; PATHOLOGY; PATIENT SELECTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROGNOSIS; PROSPECTIVE STUDY; TIME;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; BRAIN ISCHEMIA; CEREBRAL ARTERIES; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PATIENT SELECTION; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 69149108322     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235753     Document Type: Article

References (19)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
3. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moye LA, Hill MD, Wojner AW: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-2178.
4. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, Grotta JC: Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 2000; 31: 1812-1816.
5. Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, Alexandrov AV: Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001; 32: 89-93.
6. Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV: Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003; 34: 695-698.
7. Labiche LA, Malkoff M, Alexandrov AV: Residual flow signals predict complete recanalization in stroke patients treated with TPA. J Neuroimaging 2003; 13: 28-33.
8. Linfante I, Llinas RH, Selim M, Chaves C, Kumar S, Parker RA, Caplan LR, Schlaug G: Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 2002; 33: 2066-2071.
9. Ribo M, Alvarez-Sabin J, Montaner J, Romero F, Delgado P, Rubiera M, Delgado-Mederos R, Molina CA: Temporal profile of re canalization after intravenous tissue plas minogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006; 37: 1000-1004.
10. Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S, Akhtar N, Orouk FO, Salam A, Shuaib A, Alexandrov AV: Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38: 948-954.
11. Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, Gass A, Nolte C, Kucinski T, Rother J, Siebler M, Singer OC, Szabo K, Villringer A, Schellinger PD: Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004; 35: 109-114.
12. Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, Tomanek A, Frayne R, Buchan AM: Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005; 76: 1528-1533.
13. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
14. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y: Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006; 37: 1810-1815.
15. Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T: Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke. J Neurol Sci 2008; 267: 57-61.
16. Demchuk AM, Felburg RA, Alexandrov AV: Clinical recovery from acute ischemic stroke after early reperfusion of the brain with intravenous thrombolysis. N Engl J Med 1999; 340: 894-895.
17. Itoh T, Matsumoto M, Handa N, Maeda H, Hougaku H, Hashimoto H, Etani H, Tsukamoto Y, Kamada T: Rate of successful recording of blood flow signals in the middle cerebral artery using transcranial Doppler sonography. Stroke 1993; 24: 1192-1195.
18. Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS: Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERICI and Multi MERCI Part I trials. Stroke 2007; 38: 1274-1280.
19. Furst G, Saleh A, Wenserski F, Malms J, Cohnen M, Aulich A, Neumann-Haefelin T, Schroeter M, Steinmetz H, Sitzer M: Reliability and validity of noninvasive imaging of internal carotid artery pseudo-occlusion. Stroke 1999; 30: 1444-1449.